Apolipoprotein C-III: From Pathophysiology to Pharmacology
MetadataShow full item record
© 2015 Elsevier Ltd. All rights reserved. Apolipoprotein C-III (apoC-III) has a critical role in the metabolism of triglyceride (TG)-rich lipoproteins (TRLs). Animal models lacking the APOC3 gene exhibit reduced plasma TG levels, whereas the overexpression of APOC3 leads to increased TG levels. In humans, loss-of-function mutations in APOC3 are associated with reduced plasma TG levels and reduced risk for ischemic vascular disease and coronary heart disease. Several hypolipidemic agents have been shown to reduce apoC-III, including fibrates and statins, and antisense technology aimed at inhibiting APOC3 mRNA to decrease the production of apoC-III is currently in Phase III of clinical development. Here, we review the pathophysiological role of apoC-III in TG metabolism and the evidence supporting this apolipoprotein as an emerging target for hypertriglyceridemia (HTG) and associated cardiovascular disorders.
Showing items related by title, author, creator and subject.
Kurniawan, Dede Indra (2007)Background. Muscle cramps are one of the adverse affects suffered by hypercholesterolemia patients who are treated with statins. Besides reducing cholesterol levels, statins also reduce coenzyme Q10 (CoQ10) blood levels. ...
Lowering the phase trap damage in the tight gas reservoirs by using interfacial tension (IFT) reducersLu, Y.; Bahrami, Hassan; Hossain, Mofazzal; Jamili, A.; Ahmed, A.; Qiu, C. (2013)Tight-gas reservoirs have low permeability and significant damage. When drilling the tight formations, wellbore liquid invades the formation and increases water saturation of the near wellbore area and significantly ...
Florentine, Singarayer K. (1999)The WA coolibah tree, Eucalyptus victrix L. Johnson & K. Hill forms an unique and pristine woodland in the Fortescue Valley, in the Pilbara district of Western Australia. Until recently, no research had been done on E. ...